Online ISSN: 2515-8260

Assessment of Efficacy of High versus Low–Medium Prednisone Doses for the Treatment of Systemic Lupus Erythematosus Patients

Main Article Content

Arun Kumar1 , Rachel Oommen Joseph2 , *Sabu Augustine3

Abstract

Background: To compare efficacy of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients. Materials and Methods: Seventy- four adults patients diagnosed with systemic lupus erythematosus of either gender was divided equally (37) into 2 groups. Group I received prednisone doses ≤30 mg/day and group II received prednisone doses >30 mg/day. Activity was measured using the SLEDAI-2K score. Damage accrual was calculated using the SLICC damage index (SDI).

Article Details